PDL BioPharma (PDLI) Misses Q1 EPS by 8c, Miss on Revenues
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.01, $0.08 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $38.5 million versus the consensus estimate of $56.9 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
